Kadimastem Received Response from FDA:
Not compatible with Internet Explorer
Not compatible with Internet Explorer
Not compatible with Internet Explorer
- Oct 6, 2014
- 2 min
Kadimastem Approached the FDA Regarding Its ALS Treatment
- Aug 3, 2014
- 2 min
Kadimastem to collaborate with Merck Serono to advance efforts in neurodegenerative diseases
- Jun 20, 2014
- 2 min
Chief Scientist Increases Budget to Advance Kadimastem's Cell Therapy for ALS
- Jun 18, 2014
- 3 min
Success in Kadimastem’s First Pre-Clinical Trial for Treatment of Amyotrophic Lateral Sclerosis (ALS
- Jun 2, 2014
- 2 min
Kadimastem Receives Approval for U.S. Patent
- Mar 19, 2014
- 2 min
Leading pharma entrepreneur Avi Meizler believes in Kadimastem!
- Feb 3, 2014
- 2 min
Kadimastem announces its intention to reduce the exercise price for warrants (Series 1)
- Jan 5, 2014
- 3 min
Kadimastem Augments the Company's ALS Activities
- Dec 23, 2013
- 3 min
Kadimastem has received approval from the OCS to promote cell therapy
- Nov 4, 2013
- 2 min
Merck Serono and Kadimastem MOU on Drug Screening and Discovery for Neurodegenerative Diseases
- Jun 9, 2013
- 1 min
Kadimastem successfully completes an IPO and raised $5.5 Million USD
- Apr 4, 2012
- 2 min
Pharmaceutical Company Merck Serono signs an agreement: Use Kadimastem's platform for drug screening
- Feb 22, 2012
- 1 min
Dr. Eli Opper, joined Kadimastem's team of Advisors
- Jan 17, 2012
- 1 min
Kadimastem appointed Mr. Ofer Haviv as a director
- Jun 12, 2011
- 1 min
The new Chief Scientist, Mr. Avi Hasson visits Kadimastem
- Jun 6, 2010
- 1 min
The Chief Scientist visits Kadimastem